Similarly, weekly intermittent “pulses” of high‐dose erlotinib (1500 mg) resulted in CSF concentrations above half‐maximal inhibitory concentrations against lung cancer cells with EGFR mutations in patients with leptomeningeal metastases.16 This evidence concerns the gene EGFR and lung cancer.